Marietta Investment Partners’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
– Sell
-3,137
Closed -$859K – 140
2018
Q1
$859K Buy
3,137
+20
+0.6% +$6.21K 0.26% 81
2017
Q4
$993K Sell
3,117
-100
-3% -$32.1K 0.28% 75
2017
Q3
$1.01M Buy
+3,217
New +$953K 0.3% 68
2017
Q2
– Sell
-1,387
Closed -$379K – 133
2017
Q1
$379K Buy
1,387
+24
+2% +$6.79K 0.13% 106
2016
Q4
$387K Buy
+1,363
New +$404K 0.14% 99
2015
Q3
– Sell
-16,548
Closed -$6.68M – 118
2015
Q2
$6.68M Sell
16,548
-160
-1% -$64.2K 2.6% 10
2015
Q1
$7.05M Sell
16,708
-2,333
-12% -$920K 2.76% 7
2014
Q4
$6.46M Sell
19,041
-166
-0.9% -$53.7K 2.59% 7
2014
Q3
$6.35M Buy
19,207
+127
+0.7% +$41.9K 2.82% 6
2014
Q2
$6.02M Sell
19,080
-1,428
-7% -$430K 2.49% 8
2014
Q1
$6.27M Sell
20,508
-11,634
-36% -$3.69M 2.43% 6
2013
Q4
$8.99M Sell
32,142
-1,614
-5% -$417K 3.27% 3
2013
Q3
$8.13M Buy
33,756
+309
+0.9% +$69.2K 3.22% 1
2013
Q2
$7.2M Buy
+33,447
New +$7.15M 3.11% 3

Other funds holding BIIB

Marietta Investment Partners's BIIB Position: Q2 2018 in Review

Marietta Investment Partners sold out of Biogen (BIIB) in Q2 2018, closing a stake of 3,137 shares — an estimated $859K sold.

Marietta Investment Partners first reported a position in BIIB in Q2 2013 and held it in 14 quarters. The position peaked at $8.99M in Q4 2013. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

  • Marietta Investment Partners reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
  • Marietta Investment Partners sold 3,137 Biogen shares in Q2 2018, an estimated $859K.
  • Marietta Investment Partners first reported a position in Biogen in Q2 2013 and held it in 14 quarters.
  • Marietta Investment Partners's Biogen position peaked at $8.99M in Q4 2013.
  • 1,098 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on Marietta Investment Partners's 13F filing for Q2 2018, filed 9 Aug 2018.